ArticleCell & bioscience2015

Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences.

Ogyi Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.